Cortisone Acetate Induced Acute Flare-Up of HBV Infection in a Growth Hormone Deficient Patient

  • Ergenekon Karagöz GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey https://orcid.org/0000-0002-5473-3897
  • Mustafa Hatipoğlu GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
  • Vedat Turhan GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey https://orcid.org/0000-0001-5953-7951
  • Asım Ülçay GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
  • Ali Acar GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
  • Metin Alıs GATA Haydarpaşa Training Hospital, Department of Endocrinology, Istanbul, Turkey
  • Oral Öncül GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
  • Levent Görenek GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
Keywords: Hepatitis B, Growth hormone

Abstract

Reactivation of hepatitis B virus is a known complication of immunosuppressive therapy and may cause liver failure and even death. A twenty-year-old male patient visited the endocrinology department because of short stature and diagnosed as growth hormone deficient. Somatropin and cortisone acetate were initiated. After six months, HBV reactivation was occurred. Antiviral treatment with lamivudine was initiated after the increase in transaminases. After a six months’ initiating lamivudine therapy, his physical examination and laboratory test results were found to be normal. In conclusion, every patient who are planned to be received immunosuppressive therapy should be screened for HBV infection.

Author Biographies

Ergenekon Karagöz, GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

Mustafa Hatipoğlu, GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

Vedat Turhan, GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

Asım Ülçay, GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

Ali Acar, GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

Metin Alıs, GATA Haydarpaşa Training Hospital, Department of Endocrinology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Endocrinology, Istanbul, Turkey 

Oral Öncül, GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

Levent Görenek, GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

GATA Haydarpaşa Training Hospital, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

Clinical course of the patient.
Published
2014-06-02
How to Cite
Karagöz, E., Hatipoğlu, M., Turhan, V., Ülçay, A., Acar, A., Alıs, M., Öncül, O., & Görenek, L. (2014). Cortisone Acetate Induced Acute Flare-Up of HBV Infection in a Growth Hormone Deficient Patient. Disease and Molecular Medicine, 2(2), 41-44. https://doi.org/10.5455/dmm.20140411125211
Section
Case Report